Neuropace Inc
NPCE
Revenue
19.26M
▲1.13M▲6.25%
3 Months ChangeAssets
94.39M
▼-4.46M▼-4.52%
3 Months ChangeLiabilities
84.50M
▼-8.00k▼-0.009466%
3 Months ChangeFree Cash Flow
-7.63M
▲2.20M▲22.36%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-08-13
Form 10-Q
ID: 0001528287-24-000016
2024-08-13
Form 8-K
ID: 0001528287-24-000015
2024-06-10
Form 8-K
ID: 0001193125-24-158459
2024-05-08
Form 10-Q
ID: 0001528287-24-000011
2024-05-08
Form 8-K
ID: 0001528287-24-000010
2024-03-05
Form 8-K
ID: 0001528287-24-000004
2024-02-07
Form 8-K
ID: 0001193125-24-026756
2024-01-08
Form 8-K
ID: 0001193125-24-003861
2023-12-04
Form 8-K
ID: 0001193125-23-288474
2023-11-06
Form 10-Q
ID: 0001528287-23-000041